DMK Pharmaceuticals Regains Full Rights to Commercialize ZIMHI

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/20/2026

1. TGT
2. EL
3. SPY
4. BILL
5. MRK
6. MRNA
7. ADI
8. LOW
9. TJX
10. DE

Go back to DMK Pharmaceuticals Regains Full Rights to Commercialize ZIMHI
(NASDAQ: DMK) Delayed: 0.23 --0 (-0%)
Previous Close $0.23    52 Week High $ 
Open $1.88    52 Week Low $ 
Day High $0.23    P/E N/A 
Day Low $0.23    EPS $ 
Volume 49,012